Cargando…
Incidence, Risk Factors, and Outcomes of Arterial Thromboembolism in Patients with Pancreatic Cancer Following Palliative Chemotherapy
Background: Few studies have explored the association between pancreatic cancer and arterial thromboembolism (aTE). Methods: A total of 838 consecutive patients receiving palliative chemotherapy for pancreatic cancer between 2010 and 2016 were retrospectively enrolled. The clinical characteristics o...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267556/ https://www.ncbi.nlm.nih.gov/pubmed/30424491 http://dx.doi.org/10.3390/cancers10110432 |
_version_ | 1783376101741953024 |
---|---|
author | Hung, Yu-Shin Chen, Jen-Shi Chen, Yen-Yang Lu, Chang-Hsien Chang, Pei-Hung Chou, Wen-Chi |
author_facet | Hung, Yu-Shin Chen, Jen-Shi Chen, Yen-Yang Lu, Chang-Hsien Chang, Pei-Hung Chou, Wen-Chi |
author_sort | Hung, Yu-Shin |
collection | PubMed |
description | Background: Few studies have explored the association between pancreatic cancer and arterial thromboembolism (aTE). Methods: A total of 838 consecutive patients receiving palliative chemotherapy for pancreatic cancer between 2010 and 2016 were retrospectively enrolled. The clinical characteristics of patients were analyzed to determine the incidence, risk factors, and survival outcome of aTE in patients with pancreatic cancer. Results: aTE occurred in 42 (5.0%) of 838 patients. Patients with aTE had a worse survival outcome than those without (5.1 months versus 7.8 months, hazard ratio 1.53, 95% confidence interval [CI]: 1.12–2.09). Stage IV disease, high aspartate transaminase level, and comorbidity with hypertension or atrial fibrillation were four independent predictors of aTE. A concise predictive model stratified patients into low (0–1 predictor), intermediate (2 predictors), and high (3–4 predictors) risk groups. The hazard ratios for the comparison of patients in intermediate and high risk groups with those in low risk group were 4.55 (95% CI: 2.31–8.98), and 13.3 (95% CI: 5.63–31.6), respectively. Conclusion: Patients with pancreatic cancer undergoing palliative chemotherapy have an increased risk of aTE. A predictive model showed that patients presented with 3 or 4 predictors had the highest risk for developing aTE. |
format | Online Article Text |
id | pubmed-6267556 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62675562018-12-03 Incidence, Risk Factors, and Outcomes of Arterial Thromboembolism in Patients with Pancreatic Cancer Following Palliative Chemotherapy Hung, Yu-Shin Chen, Jen-Shi Chen, Yen-Yang Lu, Chang-Hsien Chang, Pei-Hung Chou, Wen-Chi Cancers (Basel) Article Background: Few studies have explored the association between pancreatic cancer and arterial thromboembolism (aTE). Methods: A total of 838 consecutive patients receiving palliative chemotherapy for pancreatic cancer between 2010 and 2016 were retrospectively enrolled. The clinical characteristics of patients were analyzed to determine the incidence, risk factors, and survival outcome of aTE in patients with pancreatic cancer. Results: aTE occurred in 42 (5.0%) of 838 patients. Patients with aTE had a worse survival outcome than those without (5.1 months versus 7.8 months, hazard ratio 1.53, 95% confidence interval [CI]: 1.12–2.09). Stage IV disease, high aspartate transaminase level, and comorbidity with hypertension or atrial fibrillation were four independent predictors of aTE. A concise predictive model stratified patients into low (0–1 predictor), intermediate (2 predictors), and high (3–4 predictors) risk groups. The hazard ratios for the comparison of patients in intermediate and high risk groups with those in low risk group were 4.55 (95% CI: 2.31–8.98), and 13.3 (95% CI: 5.63–31.6), respectively. Conclusion: Patients with pancreatic cancer undergoing palliative chemotherapy have an increased risk of aTE. A predictive model showed that patients presented with 3 or 4 predictors had the highest risk for developing aTE. MDPI 2018-11-12 /pmc/articles/PMC6267556/ /pubmed/30424491 http://dx.doi.org/10.3390/cancers10110432 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Hung, Yu-Shin Chen, Jen-Shi Chen, Yen-Yang Lu, Chang-Hsien Chang, Pei-Hung Chou, Wen-Chi Incidence, Risk Factors, and Outcomes of Arterial Thromboembolism in Patients with Pancreatic Cancer Following Palliative Chemotherapy |
title | Incidence, Risk Factors, and Outcomes of Arterial Thromboembolism in Patients with Pancreatic Cancer Following Palliative Chemotherapy |
title_full | Incidence, Risk Factors, and Outcomes of Arterial Thromboembolism in Patients with Pancreatic Cancer Following Palliative Chemotherapy |
title_fullStr | Incidence, Risk Factors, and Outcomes of Arterial Thromboembolism in Patients with Pancreatic Cancer Following Palliative Chemotherapy |
title_full_unstemmed | Incidence, Risk Factors, and Outcomes of Arterial Thromboembolism in Patients with Pancreatic Cancer Following Palliative Chemotherapy |
title_short | Incidence, Risk Factors, and Outcomes of Arterial Thromboembolism in Patients with Pancreatic Cancer Following Palliative Chemotherapy |
title_sort | incidence, risk factors, and outcomes of arterial thromboembolism in patients with pancreatic cancer following palliative chemotherapy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267556/ https://www.ncbi.nlm.nih.gov/pubmed/30424491 http://dx.doi.org/10.3390/cancers10110432 |
work_keys_str_mv | AT hungyushin incidenceriskfactorsandoutcomesofarterialthromboembolisminpatientswithpancreaticcancerfollowingpalliativechemotherapy AT chenjenshi incidenceriskfactorsandoutcomesofarterialthromboembolisminpatientswithpancreaticcancerfollowingpalliativechemotherapy AT chenyenyang incidenceriskfactorsandoutcomesofarterialthromboembolisminpatientswithpancreaticcancerfollowingpalliativechemotherapy AT luchanghsien incidenceriskfactorsandoutcomesofarterialthromboembolisminpatientswithpancreaticcancerfollowingpalliativechemotherapy AT changpeihung incidenceriskfactorsandoutcomesofarterialthromboembolisminpatientswithpancreaticcancerfollowingpalliativechemotherapy AT chouwenchi incidenceriskfactorsandoutcomesofarterialthromboembolisminpatientswithpancreaticcancerfollowingpalliativechemotherapy |